Xu K - Search Results

1

ncRNA-mediated fatty acid metabolism reprogramming in HCC.

Xu K, Xia P, Chen X, Ma W, Yuan Y. Xu K, et al. Trends Endocrinol Metab. 2023 May;34(5):278-291. doi: 10.1016/j.tem.2023.02.007. Epub 2023 Mar 6. Trends Endocrinol Metab. 2023. PMID: 36890041 Review.

2

MYC-targeted WDR4 promotes proliferation, metastasis, and sorafenib resistance by inducing CCNB1 translation in hepatocellular carcinoma.

Xia P, Zhang H, Xu K, Jiang X, Gao M, Wang G, Liu Y, Yao Y, Chen X, Ma W, Zhang Z, Yuan Y. Xia P, et al. Among authors: xu k. Cell Death Dis. 2021 Jul 9;12(7):691. doi: 10.1038/s41419-021-03973-5. Cell Death Dis. 2021. PMID: 34244479 Free PMC article.

3

Identification of Glycolysis-Related lncRNAs and the Novel lncRNA WAC-AS1 Promotes Glycolysis and Tumor Progression in Hepatocellular Carcinoma.

Xia X, Zhang H, Xia P, Zhu Y, Liu J, Xu K, Yuan Y. Xia X, et al. Among authors: xu k. Front Oncol. 2021 Aug 30;11:733595. doi: 10.3389/fonc.2021.733595. eCollection 2021. Front Oncol. 2021. PMID: 34527595 Free PMC article.

4

YY1-Targeted RBM15B Promotes Hepatocellular Carcinoma Cell Proliferation and Sorafenib Resistance by Promoting TRAM2 Expression in an m6A-Dependent Manner.

Tan C, Xia P, Zhang H, Xu K, Liu P, Guo D, Liu Z. Tan C, et al. Among authors: xu k. Front Oncol. 2022 Apr 14;12:873020. doi: 10.3389/fonc.2022.873020. eCollection 2022. Front Oncol. 2022. PMID: 35494016 Free PMC article.

5

A novel lncRNA RP11-386G11.10 reprograms lipid metabolism to promote hepatocellular carcinoma progression.

Xu K, Xia P, Gongye X, Zhang X, Ma S, Chen Z, Zhang H, Liu J, Liu Y, Guo Y, Yao Y, Gao M, Chen Y, Zhang Z, Yuan Y. Xu K, et al. Mol Metab. 2022 Sep;63:101540. doi: 10.1016/j.molmet.2022.101540. Epub 2022 Jul 5. Mol Metab. 2022. PMID: 35798238 Free PMC article.

6

A positive feedback loop of CENPU/E2F6/E2F1 facilitates proliferation and metastasis via ubiquitination of E2F6 in hepatocellular carcinoma.

Liu Y, Yao Y, Liao B, Zhang H, Yang Z, Xia P, Jiang X, Ma W, Wu X, Mei C, Wang G, Gao M, Xu K, GongYe X, Cheng Z, Jiang P, Chen X, Yuan Y. Liu Y, et al. Among authors: xu k. Int J Biol Sci. 2022 Jun 21;18(10):4071-4087. doi: 10.7150/ijbs.69495. eCollection 2022. Int J Biol Sci. 2022. PMID: 35844791 Free PMC article.

7

A six lipid metabolism related gene signature for predicting the prognosis of hepatocellular carcinoma.

Xu K, Xia P, Liu P, Zhang X. Xu K, et al. Sci Rep. 2022 Dec 1;12(1):20781. doi: 10.1038/s41598-022-25356-2. Sci Rep. 2022. PMID: 36456877 Free PMC article.

8

Genome stability‑related lncRNA ZFPM2‑AS1 promotes tumor progression via miR‑3065‑5p/XRCC4 in hepatocellular carcinoma.

Liu J, Zhang H, Xia P, Zhu Y, Xu K, Liu Z, Yuan Y. Liu J, et al. Among authors: xu k. Int J Oncol. 2023 Feb;62(2):19. doi: 10.3892/ijo.2022.5467. Epub 2022 Dec 16. Int J Oncol. 2023. PMID: 36524359 Free PMC article.

9

METTL5 stabilizes c-Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression.

Xia P, Zhang H, Lu H, Xu K, Jiang X, Jiang Y, Gongye X, Chen Z, Liu J, Chen X, Ma W, Zhang Z, Yuan Y. Xia P, et al. Among authors: xu k. Cancer Commun (Lond). 2023 Mar;43(3):338-364. doi: 10.1002/cac2.12403. Epub 2023 Jan 5. Cancer Commun (Lond). 2023. PMID: 36602428 Free PMC article.

10

LncRNA TGFB2-OT1 Promotes Progression and Angiogenesis in Hepatocellular Carcinoma by Dephosphorylating β-Catenin.

Chen Y, Wu X, Chen X, Guo D, Ma W, Guo Y, Xu K, Ma S, Yuan Y, Zhu Q. Chen Y, et al. Among authors: xu k. J Hepatocell Carcinoma. 2023 Mar 14;10:429-446. doi: 10.2147/JHC.S404008. eCollection 2023. J Hepatocell Carcinoma. 2023. PMID: 36941998 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11,498 results

Search Page